Clinical trial
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating…
NCT00006367 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00006367 |
|---|---|
| Title | Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis |
| Official title | Autologous Peripheral Blood Stem Cell Mobilization and Transplantation for Myelofibrosis |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Myeloproliferative Disorders |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, busulfan, cytarabine, idarubicin, peripheral blood stem cell transplantation |
| Start date | May 1, 2000 |
| Completion | Jan 1, 2004 |
| First posted | Nov 11, 2003 |
| Last update posted | Jun 17, 2010 |
| Countries | France, United Kingdom, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: